Authors:
Address: Department of Veterinary Pathology, Armed Forces Institutes of Pathology, Washington, District of Columbia, USA.
Journal:
Publication:
abstractWe evaluated the susceptibility to Ebola and Marburg virus infection of mice that cannot respond to interferon (IFN)-α/β and IFN-γ because of deletion of the STAT-1 gene. A mouse-adapted Zaire ebolavirus (ZEBOV) caused rapidly lethal disease; wild-type ZEBOV and Sudan Ebolavirus and 4 different Marburg virus strains produced severe, but more slowly progressive illness; and Reston Ebolavirus caused mild disease that was late in onset. The virulence of each agent was mirrored by the pace and severity of pathologic changes in the liver and lymphoid tissues. A virus-like particle vaccine elicited strong antibody responses but did not protect against mouse-adapted ZEBOV challenge.
Related ArticlesSingle-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.J Virol. 2009
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H. J Virol. 2009 Jul; 83(14):7296-304. Epub 2009 Apr 22.
Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.J Med Microbiol. 2012
Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
Lever MS, Piercy TJ, Steward JA, Eastaugh L, Smither SJ, Taylor C, Salguero FJ, Phillpotts RJ. J Med Microbiol. 2012 Jan; 61(Pt 1):8-15. Epub 2011 Aug 18.
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.Clin Vaccine Immunol. 2008
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD. Clin Vaccine Immunol. 2008 Mar; 15(3):460-7. Epub 2008 Jan 23.
Review Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.J Infect Dis. 2011
Review Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
Geisbert TW, Feldmann H. J Infect Dis. 2011 Nov; 204 Suppl 3:S1075-81.
Review [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].Med Trop (Mars). 2011
Review [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
Leroy E, Baize S, Gonzalez JP. Med Trop (Mars). 2011 Apr; 71(2):111-21.
To
top
•
Home
Show
map | Diseases | Vaccination
| Chronic disease | Medicine
| Pregnancy
| Heat & Sunburn | Cold | Security
| Useful tips | Faq
| News
TraveldoctorOnline 2001 •
Disclaimer • webmaster
